BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Device: CESM
Device: MRI

First Posted Date: 2018-03-29

Last Posted Date: 2023-06-12

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 82

Registration Number: NCT03482557

Locations: 🇺🇸
Beth Israel Deaconess, Boston, Massachusetts, United States

Managing Side Effects in Clinical Practice

Not Applicable

Completed

Conditions: Functional Gastrointestinal Disorders

Interventions: Other: Standard of Care

First Posted Date: 2018-03-23

Last Posted Date: 2022-12-15

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 31

Registration Number: NCT03475550

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

EEG Changes With Guided Online Meditation

Not Applicable

Completed

Conditions: Meditation

Interventions: Behavioral: Meditation
Device: Enobio 32- EEG machine

First Posted Date: 2018-03-09

Last Posted Date: 2024-03-28

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 13

Registration Number: NCT03459690

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

OKS for the Treatment of Hemispatial Neglect

Not Applicable

Withdrawn

Conditions: Neglect, Sensory
Neglect, Hemispatial
Neglect, Hemisensory

Interventions: Device: OKS

First Posted Date: 2018-03-02

Last Posted Date: 2024-06-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT03451708

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Treadmill Exercise in Metabolic Syndrome

Not Applicable

Terminated

Conditions: Metabolic Syndrome

Interventions: Other: Treadmill Exercise- traditional approach
Other: Treadmill Exercise- behavioral approach

First Posted Date: 2018-02-19

Last Posted Date: 2022-05-26

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 12

Registration Number: NCT03435315

Locations: 🇺🇸
BIDMC, Boston, Massachusetts, United States

IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3

Phase 2

Completed

Conditions: Small Fiber Neuropathy
Idiopathic Peripheral Neuropathy

Interventions: Drug: 0.9% Sodium Chloride
Drug: Intravenous immunoglobulin

First Posted Date: 2018-01-17

Last Posted Date: 2023-09-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT03401073

Locations: 🇺🇸
Beth Israel Deaconness Medical Center, Boston, Massachusetts, United States

Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial

Phase 2

Completed

Conditions: Septic Shock
Sepsis
Metabolic Disturbance

Interventions: Drug: Normal saline
Drug: vitamin C, vitamin B1, hydrocortisone

First Posted Date: 2018-01-03

Last Posted Date: 2021-02-16

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 205

Registration Number: NCT03389555

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Mount Auburn Hospital, Cambridge, Massachusetts, United States

and more 10 locations

Sleep and Inflammatory Resolution Pathway

Early Phase 1

Active, not recruiting

Conditions: Inflammatory Response
Sleep Restriction
Inflammation
Sleep

Interventions: Drug: Placebo
Drug: Aspirin

First Posted Date: 2017-12-19

Last Posted Date: 2024-07-03

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 66

Registration Number: NCT03377543

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering

Not Applicable

Completed

Conditions: Shivering
Nausea and Vomiting, Postoperative

Interventions: Drug: Placebo
Drug: Dexmedetomidine

First Posted Date: 2017-12-12

Last Posted Date: 2021-10-01

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 100

Registration Number: NCT03370562

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

House Calls and Peer Mentorship

Not Applicable

Completed

Conditions: Chronic Kidney Disease
End-Stage Renal Disease

Interventions: Behavioral: House Call
Behavioral: Peer Mentorship

First Posted Date: 2017-11-28

Last Posted Date: 2024-03-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 320

Registration Number: NCT03354910

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy